Leaflet LENALIDOMIDA ALKALOID-INT 15mg capsules

Product code:
W67876002
Quantity:
21
Indicated for:
multiple myeloma
Route of administration:
oral
Substance:
lenalidomide (immunomodulator)
ATC
L04AX04 — Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Other immunosuppressants

Precautions:

Contraception required

Effective contraception is required during treatment.

Contraindicated during breastfeeding

Do not use this medicine while breastfeeding.

Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Avoid live vaccines

Avoid live vaccines during treatment if contraindicated.

Immunosuppression / infection risk

This medicine may increase the risk of infections.

Teratogenic / fetal risk

This medicine may affect fetal development.

Lenalidomide is a medication used for the treatment of multiple myeloma, myelodysplastic syndromes, and other hematologic conditions. It works by modulating the immune system and inhibiting tumor cell growth.

The medication is taken orally, usually once daily, as part of a treatment cycle prescribed by a doctor. Regular monitoring of hematologic function is important, and precautions must be taken to avoid pregnancy.

Side effects may include fatigue, anemia, neutropenia, or skin rashes. In rare cases, deep vein thrombosis or severe allergic reactions may occur.

Lenalidomide is not recommended for pregnant women or those planning to become pregnant, as well as patients with hypersensitivity to this medication.

General data about LENALIDOMIDA ALKALOID-INT 15mg

Substance:
lenalidomide
Date of latest medicines list:
01-06-2026
Product code:
W67876002
Concentration:
15mg
Pharmaceutical form:
capsules
Quantity:
21
Product type:
Generic medicine
Price:
2617.51 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
SYNTHON HISPANIA S.L. - SPANIA
Holder:
ALKALOID - INT D.O.O. - SLOVENIA
Number:
13907/2021/02

Concentrations available for lenalidomide

  • 10mg
  • 15mg
  • 2.5mg
  • 20mg
  • 25mg
  • 5mg
  • 7.5mg

Compensation lists for LENALIDOMIDA ALKALOID-INT 15mg Alkaloid

NHP 3 (C2) - NHP oncology

Price
2617.51 RON
Copayment
1506.58 RON
Patient
1110.93 RON